Animal models with potential applications for screening compounds for the treatment of obsessive-compulsive disorder

Bibliography

• WILLNER P: Methods for assessing the validity of animal models of human psychopathology. In: Animal Models in Psychiatry L Boulton AA, Baker GB, Martin-Iverson MT (Eds.), Humana Press, New Jersey (1991).
   Google Scholar
• ZOHAR J, INSEL TR: Obsessive-compulsive disorder: psy-chobiological approaches to diagnosis, treatment and pathophysiology. Biol. Psychiatry (1987) 22:667–687.
   PubMed Web of Science ®Google Scholar
• INSEL TR: Toward a neuroanatomy of obs ess ive-compul-sive disorder. Arch. Gen. Psychiatry (1992) 49:739–744.
   PubMed Web of Science ®Google Scholar
• RAPOPORT JL: Recent advances in obsessive-compulsive disorder. Neuropsychopharmacology (1991) 49:739–744.
   Google Scholar
• MCDOUGLE CJ, SOUTHWICK SM, ROHRBAUGH RM: Tourette's disorder and associated complex behav-iours: a case report. Yale J. Biol. Mod. (1990) 63:209–214.
   PubMed Web of Science ®Google Scholar
• HOLLANDER E, DE CARTA CM, NITESCO A et al.: Seroton-ergic function in obsessive-compulsive disorder. Arch. Gen. Psychiatry (1992) 49:21–28.
   PubMed Web of Science ®Google Scholar
• MARAZZITI D, ROSSI A, GEMIGNANI A et al.: Decreased platelet [311]-paroxetine binding in obsessive-compul-sive patients. Neuropsychobiology (1996) 34:184–187.
   PubMed Web of Science ®Google Scholar
• GOODMAN WK, PRICE LH, DELGADO PL et al: Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Arch. Gen. Psychiatry (1990) 47:577–585.
   PubMed Web of Science ®Google Scholar
• JENIKE MA, HYMAN S, BAER L et al.: A controlled trial of fluvoxamine in obsessive-compulsive disorder: impli-cation for a serotonergic theory. Am. J. Psychiatry (1990) 147:1209–1214.
   PubMed Web of Science ®Google Scholar
• LEONARD HL, SVVEDO SE, RAPOPORT JL, COFFEY M, CFI:BLOW D Treatment of childhood obsessive compul-sive disorder with clomipramine and desmethylimipramine: a double-blind crossover comparison. Psycho-pharmacol Bull. (1988) 24:93–95.
   PubMed Web of Science ®Google Scholar
• LEONARD HL, SWEDO SE, RAPOPORT JL eta].: Treatment of obsessive-compulsive disorder with clomipramine and des ipramine in children and adolescents. Arch. Gen. Psychiatry (1989) 46:1088–1092.
   Google Scholar
• GOODMAN WK, MCDOUGLE CI PRICE LH: Pharma-cotherapy of obsessive compulsive disorder. J. Clin. Psychiatry (1992) 53:29–37.
   PubMed Web of Science ®Google Scholar
• HEWLETT WA, VINOGRADOV S, AGRAS WS: Clomi-pramine, clonazepam, and clonidine treatment of ob-sessive-compulsive disorder. J. Clin. Psychopharmacol (1992) 12:420–429.
   PubMed Web of Science ®Google Scholar
• JENIKE MA, BAER L: An open trial of buspirone in obsessive-compulsive disorder. Am. J. Psychiatry (1988) 145:1285–1286.
   PubMed Web of Science ®Google Scholar
• HOLLANDER E, DECARIA C, NITESCU A et al.: Noradren-ergic function in obsessive-compulsive disorder: be-havioural and neuroendocrine responses to clonidine and comparison to healthy controls. Psychiatry Res. (1991) 37:161–177.
   PubMed Web of Science ®Google Scholar
• KNESEVICH JW: Successful treatment of obsessive-com-pulsive disorder with clonidine hydrochloride. Am. J. Psychiatry (1982) 139:364–365.
   PubMed Web of Science ®Google Scholar
• INSEL TR, ZOHAR J, BENKELFAT C, MURPHY DL: Sero-tonin in obsessions, compulsions and control of aggres - sive impulses. Ann. NY Acad. Sci. (1990) 600:574–586.
   PubMed Web of Science ®Google Scholar
• INSEL TR, PICKAR D: Naloxone administration in obses-sive-compulsive disorder: report of two cases. Am. J. Psychiatry (1983) 140:1219–1220.
   PubMed Web of Science ®Google Scholar
• JACOBSEN, FM: Risperidone in the treatment of affective illness and obsessive-compulsive disorder. J. Clin. Psy-chiatry (1995) 56:423–424.
   Web of Science ®Google Scholar
• MEGAN JB: Treatment of obsessive-compulsive neuro-sis with haloperidol. Can. Med. Assoc. J. (1990) 103:167–168.
   Google Scholar
• AUERBACH SB, LUNDBERG JF, HJORTH S: Differential inhibition of serotonin release by 5-HT and norad-renaline reuptake blockers after systemic administra-tion. Neuropharmacology (1995) 34:89–96.
   PubMed Web of Science ®Google Scholar
• MCDOUGLE CI GOODMAN WK, LECKMAN JF et al: Halop-eridol addition in fluvoxamine-refractory obsessive-compulsive disorder. Arch. Gem Psychiatry (1994) 51:302–308.
   PubMedGoogle Scholar
• GOODMAN WK, MCDOUGLE CI PRICE LH et a].: Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive- compulsive disorder. Lin. Psychiatry (1990) 51:36–43.
   Web of Science ®Google Scholar
• PITMAN RK: Animal models of compulsive behaviour. Biol. Psychiatry (1989) 26:189–198.
   PubMed Web of Science ®Google Scholar
• RANDRUP A, MUNKVAD I: Stereotyped activities pro-duced by amphetamine in several animal species and man. Psychopharmacology (1967) 11:300–310.
   PubMed Web of Science ®Google Scholar
• FRANBLAUST SH, KANADANIAN M, RETTIG E: Critique of reductionistic models of obsessive-compulsive disor-der: toward a new explanatory paradigm. Soc. ScL Med (1995) 41:99–112.
   PubMed Web of Science ®Google Scholar
• RIDLEY RM: The psychology of perseveration and stereotyped behaviour process in neurobiology. Progr. Neurobiol (1994) 44:221–231.
   PubMed Web of Science ®Google Scholar
• RIDLEY RM, BAKER HF: Stereotypy in monkeys and humans. Psycho]. Med. (1982) 12:61–72.
   PubMed Web of Science ®Google Scholar
• RAPOPORT JL, RYLAND DH, KRUTE M: Drug treatment of canine acral lick: an animal model of OCD. Arch. Gen. Psychiatry (1992) 49:517–520.
   PubMed Web of Science ®Google Scholar
• GRINDLINGER E, RAPOPORT J: Canine dermatitis: re-sponse to the anti-obsessional drug. J. Am. Hosp. Assoc. (1991) 22:179–182.
   Google Scholar
• STEIN DJ, SHOULBERG N, HELTON K, HOLLANDER E: The neuroethological approach to obsessive-compulsive disorder. Comp. Psychiatry (1992) 33:274–281.
   PubMed Web of Science ®Google Scholar
• HARTMANN L: Cats as possible obsessive-compulsive disorder and medication models. Am. J. Psychiatry (1995) 152:1236.
   PubMed Web of Science ®Google Scholar
• NURNBERG HG, KEITH SI PAXTON DM: Consideration of the relevance of ethological animal models for hu-man repetitive behavioral spectrum disorders. Biol. Psychiatry (1997) 41:226–229.
   PubMed Web of Science ®Google Scholar
• BROWN SA, CROWELL-DAVIS S, MALCOLM T, EDWARDS P: Naloxone-responsive compulsive tail chasing in a dog. JAVMA (1987) 190:884–886.
   PubMed Web of Science ®Google Scholar
• DODMAN NH, SHUSTER L, WHITE SD et al.: Use of narcotic antagonists to modify stereotypic self-licking, self-chewing and scratching behaviour in dogs. JAVMA (1988) 193:815–819.
   PubMed Web of Science ®Google Scholar
• SCHWARTZ S: Naltrexone-induced pruritus in a dog with tail chasing behaviour. JAVMA (1993) 202:278–280.
   PubMed Web of Science ®Google Scholar
• WHITE SD: Naltrexone for treatment of acral lick der-matitis in dogs. JAVMA (1990) 196:1073–1076.
   PubMed Web of Science ®Google Scholar
• FOG R, PARKENBERG H: Behavioral effects of dopamine and p-hydroxyamphetamine injected into corpus striatum of rats. Exp. Neurol. (1971) 31:75–86.
   PubMed Web of Science ®Google Scholar
• DELFS JM, KELLEY AE: The role of Di and Dy dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum. Neuroscience (1990) 39:59–67.
   PubMed Web of Science ®Google Scholar
• YEGHIAYAN SK, KELLEY AE: Serotonergic stimulation of the ventrolateral striatum induces orafacial stereotypy. Pharmacol Biochem. Behav. (1995) 52:493–501.
   PubMed Web of Science ®Google Scholar
• WINSLOW J, INSEL TR: Neuroethological models of ob-sessive-compulsive disorder. In: The Psychobiology of Obsessive-Compulsive Disorder. Zohar J, Insel T, Rasmussan S (Eds.), Springer Publishing Co., New York, NY (1991).
   Google Scholar
• FALK JL: Theoretical review of the nature and determi-nants of adjunctive behaviour. PhysioL Behav. (1971) 6:577–588.
   PubMed Web of Science ®Google Scholar
• FALK JL: The origin and functions of adjunctive behav-iour. Anima] Learning Behav. (1977) 4:325–335.
   Google Scholar
• INSEL TR: Obsessive-compulsive disorder: new models. PsychopharmacoL Bull. (1988) 24:365–369.
   PubMed Web of Science ®Google Scholar
• WOODS A, SMITH C, SZEWCZAK M et al.: Selective sero-tonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder. Psychopharmacology (1993) 122:195–198.
   Google Scholar
• WOODS-KETTELBERGER AT, SMITH CP, CORBETT R eta].:Besipirdine (HP 749) reduces schedule-induced poly-dipsia in rats. Brain Res. Bull. (1996) 41:125–130.
   Google Scholar
• RAUCH SL, O'SULLIVAN RL, JENIKE MA: Open treatment of obsessive-compulsive disorder with venlafaxine: a series of ten cases. J. Clin. Psychiatry (1992) 53:4–10.
   Google Scholar
• BECH P: Acute therapy of depression. J. Clin. Psychiatry (1993) 54:18–27.
   PubMed Web of Science ®Google Scholar
• COOPER SH, HOTLZMAN SG: Patterns of drinking in the rat following the administration of opiate antagonists. Pharmacol. Biochem. Behav. (1983) 19:505–511.
   PubMed Web of Science ®Google Scholar
• KURIBARA H, TADOKORO S: Effects of psychotropic drugs on Fl responding and adjunctive drinking in rats. Pharmacol. Biochem. Behav. (1980) 13:657–662.
   PubMed Web of Science ®Google Scholar
• MITTLEMAN G, JONES GH, ROBBINS TW: Effects of diaze-pam, FG 7142 and RO 15-1788 on schedule-induced polydipsia and the temporal control of behaviour. Psychopharmacology (1988) 94:103–109.
   PubMed Web of Science ®Google Scholar
• SMITH CP, WOODS-KETTELBERGER AT, CORBETT R et al.: Anti-obsessional and antidepressant profile of be-sipirdine. CNS Drug Rev. (1997) 3:1–23.
   Google Scholar
• HYASHI T, NISHIKAWA T, KOGA I eta].: Involvement of the ay-adrenergic system in polydipsia in schizo-phrenic patients: a pilot study. Psychopharmacology (1997) 130:382 386.
   Google Scholar
• ROEHR J, WOODS A, CORBETT R, KONGSAMUT S: Changes in paroxetine binding in the cerebral cortex of polydipsic rats. Eur. J. Pharmacol. (1995) 278:75–78.
   PubMed Web of Science ®Google Scholar
• ALTEMUS M, GLOWCA JR, MURPHY DL: Attenuation of food-restriction-induced running by chronic fluoxet-ine treatment. Psychopharmacol. Bull. (1993) 29:397–400.
   PubMed Web of Science ®Google Scholar
• ALTEMUS M, GLOWA JR, GALLIVEN E, LEONG YM, MUR-PHY DL: Effects of serotonergic agents on food-restric-tion-induced hyperactivity. Pharmacol. Biochem. Behav. (1996) 53:123–131.
   PubMed Web of Science ®Google Scholar
• GYERTYAN I: Analysis of the marble burying response: marbles serve to measure digging rather than evoke behaviour. Behav. Pharmacol. (1995) 6:24–31.
   PubMed Web of Science ®Google Scholar
• ICHIMARU Y, EGAWA T, SAWA A: 5-HT1A -receptor sub-type mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying be-haviour in mice. Jpn. J. Pharmacol. (1995) 68:65–70.
   PubMedGoogle Scholar
• NJUNG'E K, HANDLEY SL: Evaluation of marble burying behaviour as a model of anxiety. Pharmacol. Biochem. Behav. (1991) 38:63–67.
   PubMed Web of Science ®Google Scholar
• OLIVIER B: Animal models in obsessive compulsive disorder. Int. Clin. Psychopharmacol. (1992) 7:27–29.
   PubMed Web of Science ®Google Scholar
• TULP M, OLIVIER B, SCHIPPER J et al.: Serotonin reuptake blockers: is there pre clinical evidence for their efficacy in obsessive-compulsive disorder? Human Psychophar-macol. (1991) 6:63–71.
   Google Scholar
• DE VRY J, BENZ U, SCHRIEBER R, TRABER J: Shock-in-duced ultrasonic vocalisation in young adult rats: a model for testing putative anti-anxiety drugs. Eur. Pharmacol. (1993) 249:331–339.
   PubMed Web of Science ®Google Scholar
• MOLEWIJK HE, VAN DER POEL AM, MOS J, VAN DER HEYDEN JAM, OLIVIER B: Conditioned ultrasonic dis-tress vocalisations in adult male rats as a behavioral paradigm for screening anti-panic drugs. Psychophar-macology(199S) 117:32–40.
   Google Scholar
• NJUNG EK, HANDLEY SL: Effects of 5-HT uptake inhibi-tors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents. Br. J. Pharmacol. (1991) 104:105–112.
   PubMed Web of Science ®Google Scholar
• PORSOLT RD, BERTIN A, JALFRE M: Behavioural despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. (1977) 229:327–336.
   PubMedGoogle Scholar
• BORSINI F, MELT A: Is the forced swimming test a suitable model for revealing antidepressant activity?Psychopharmacology (1988) 94:147–160.
   PubMed Web of Science ®Google Scholar
• DETKE MJ, LUCKI I: Detection of serotonergic and nor-adrenergic antidepressants in the rat forced swimming test: the effects of water depth. Behav. Brain Res. (1996) 73:43–46.
   PubMed Web of Science ®Google Scholar
• SELIGMAN MEP, MAIER SF: Failure to escape traumatic shock. J. Exp. Psycho]: (1967) 74:1–9.
   PubMed Web of Science ®Google Scholar
• CESANA R, CECI A, CIPRANDI C, BORSINI F: Mesulergine antagonism towards the fluoxetine anti-immobility ef-fect in the forced swimming test in mice. J. Pharm. Pharmacol. (1993) 45:473–475.
   PubMed Web of Science ®Google Scholar
• DUTERTE-BOUCHER D, LECLERE JF, PANISSAUD C, COS-TENTIN J: Acute effects of direct dopamine agonists in the mouse behavioral despair test. Eur. j Pharmacol. (1988) 154:185–190.
   PubMed Web of Science ®Google Scholar
• RAVARD S, CARNOY P, HERVE D et al.: Involvement ofprefrontal dopamine neurones in behavioral blockade induced by controllable vs. uncontrollable negative events in rats. Behav. Brain Res. (1990) 37:9–18.
   PubMed Web of Science ®Google Scholar
• MARTIN JV, EDWARDS E, JOHNSON JO, HENN F: Monoamine receptors in an animal model of affective disorder. J. Neurochem. (1990) 55 :1142–1148.
   PubMed Web of Science ®Google Scholar
• MARTIN P, SOUBRIE P, PUECH AJ: Reversal of helpless behaviour by serotonin uptake blockers in rats. Psycho-pharmacology (1990) 101:403–407.
   PubMed Web of Science ®Google Scholar
• PLAZNIK A, TAMBORSKA E, HAUPTMANN M, BIDZINSKI A, KOSTOWSKI W: Brain neurotransmitter systems me-diating behavioral deficits produced by inescapable shock treatment in rats. Brain Res. (1988) 447:122–132.
   PubMed Web of Science ®Google Scholar
• CANON JG, LIPPA AS: Effects of clozapine, chlorpro-mazine and diazepam upon adjunctive and schedule controlled behaviours. Pharmacol. Biochem. Behav. (1977) 6:581–587.
   PubMed Web of Science ®Google Scholar
• PELLON R, BLACKMAN DE: Effects of drugs on the tem-poral distribution of schedule-induced polydipsia in rats. Pharmacol. Biochem. Behav. (1992) 43:689–695.
   PubMed Web of Science ®Google Scholar
• SNODGRASS SH, ALLEN JD: Effect of dopamine agents on schedule-and deprivation-induced drinking in rats. Pharmacol. Biochem. Behav. (1987) 27:463–475.
   PubMed Web of Science ®Google Scholar
• SNODGRASS SH, ALLEN JD: The effects of apomorphine on the acquisition of schedule-induced polydipsia in rats. Pharmacol. Biochem. Behav. (1988) 29:483–488.
   PubMed Web of Science ®Google Scholar
• SANGER DJ, CORNFIELD-SUMNER PK: Schedule-induced drinking and thirst: a pharmacological analysis. Phar-macol. Biochem. Behav. (1979) 10:471–474.
   PubMed Web of Science ®Google Scholar
• RILEY AL, WETHFRINGTON CL: The differential effects ofnaloxone hydrochloride on the acquisition and main-tenance of schedule-induced polydipsia. Pharmacol. Biochem. Behav. (1967) 26:677–681.
   Google Scholar
• TODD KG, BECK HM, MARTIN-IVERSON T: Effects of Diand Dy dopamine antagonists on behaviour of polydip-sic rats. Pharmacol. Biochem. Behav. (1992) 42:381–388.
   PubMedGoogle Scholar
• GIANO R, SALES GD, RENNA G, RACAGNI G, CUOMO V: Ultrasonic vocalisation in rat ups: effects of early post-natal exposure to haloperidol. Life Sci. (1986) 38:1417–1423.
   PubMed Web of Science ®Google Scholar
• EKKAMP CL, RUK HW, JOLY-GELOUIN, LLOYD KL: Major tranquillizers on the basis of effects on marble burying and swim-induced grooming in mice. Eur. j Pharmacol 1986) 126:223–229.
   PubMedGoogle Scholar
• SOUBRIE P, MARTIN P, EL MESTIKAWY S et al.: The lesion of serotonergic neurons does not prevent antidepres-sant-induced reversal of escape failures produced by inescapable shocks in rats. Pharmacol. Biochem. Behav. (1986) 25:1–6.
   Google Scholar